Issue 76, 2020

Recent advances in the development of anti-infective peptoids

Abstract

In the search for new sources of antimicrobials many researchers have investigated antimicrobial peptides (AMPs) as templates for the design of innovative therapeutics. However, efforts to develop AMPs in this area has been severely hampered by their inherent susceptibility to enzymatic degradation. Given this only a handful of AMPs are currently in clinical trials. Peptide mimetics such as peptoids have emerged as highly promising alternatives to AMPs as they are inherently stable to enzymatic degradation and display potent antimicrobial properties. This feature article highlights the progress that has been made towards the development of novel anti-infective peptoids.

Graphical abstract: Recent advances in the development of anti-infective peptoids

Article information

Article type
Feature Article
Submitted
07 Jul 2020
Accepted
24 Aug 2020
First published
28 Aug 2020

Chem. Commun., 2020,56, 11158-11168

Recent advances in the development of anti-infective peptoids

K. L. Bicker and S. L. Cobb, Chem. Commun., 2020, 56, 11158 DOI: 10.1039/D0CC04704J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements